"Diagnostics for high consequence infections: discovery to market"
This talk is for PSI staff and students. Members of the University who are not at the PSI are welcome to join, but please contact us beforehand to let us know (events.psi@ndm.ox.ac.uk).
Diagnostics impact every part of a pandemic from testing of the first case and upscale during outbreaks to confirmation of elimination and surveillance. Dr Adams will talk about her work in diagnostic discovery, development and evaluation in pandemic related disease. She will highlight the challenges of getting tests to market and the value of partnerships.

Dr. Emily Adams recently joined PSI as a Principal Investigator and is also the Chief of Global Health at GADx, a UK-based social enterprise focused on diagnostics. She leads the global health portfolio, strategy, and business development activities at GADx. Emily combines academic research and industry expertise to bring high-potential diagnostic tests to market and maximize their impact.

The seminar will take place from 12:30 to 13:30 in the BDI building, seminar rooms, followed by lunch and networking from 13:30 to 14:30.
Date: 22 October 2024, 12:30 (Tuesday, 2nd week, Michaelmas 2024)
Venue: Big Data Institute, Old Road Campus OX3 7LF
Venue Details: Seminar Rooms 0&1, Big Data Institute, Old Road Campus OX3 7LF
Speaker: Dr Emily Adams (University of Oxford)
Organising department: Nuffield Department of Clinical Medicine
Organisers: James Hay (Wellcome Trust Early Career Fellow), Ksenia Ananyeva (University of Oxford)
Organiser contact email address: events.psi@ndm.ox.ac.uk
Host: Pandemic Sciences Institute
Part of: Pandemic Sciences Institute seminar series
Booking required?: Required
Booking url: https://forms.office.com/Pages/ResponsePage.aspx?id=G96VzPWXk0-0uv5ouFLPkfqJsIz1OHtImXkbS9R4tRRUQlhENFBHVThOU01GTktHMU8zMk1FREZIRy4u
Cost: Free
Audience: Members of the University only
Editor: Ksenia Ananyeva